Ilant Health Review
Best for: Employer and health-plan members wanting value-based obesity GLP-1 care
Ilant Health is a value-based obesity and cardiometabolic care company distributed through employers and health plans rather than direct cash-pay. Its team of board-certified obesity providers, behavioral-health specialists, dietitians, and navigators uses data-driven stratification to match patients to interventions including GLP-1s, with predictable drug pricing for plan sponsors. Ilant markets outcomes such as about 15 percent one-year weight reduction and biometric remission. As a managed-care solution for organizational buyers, individuals generally cannot enroll without sponsorship.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Ilant Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
✓ Pros
- •Value-based, outcomes-driven obesity care model
- •Includes GLP-1 medications with transparent drug pricing for sponsors
- •Care team of board-certified obesity providers and behavioral specialists
- •Dietitians and peer navigators support adherence
- •Data-driven stratification targets the right interventions
- •Reported around 15 percent one-year weight reduction
✗ Cons
- •Distributed via employers and health plans, not direct cash-pay
- •Individuals generally cannot enroll without sponsor coverage
- •No public consumer pricing for GLP-1
- •Access gated behind organizational buyers
- •Not suited to consumers wanting direct-to-door GLP-1
Ready to start with Ilant Health?
See current pricing and start your free consultation.
Sources & methodology
Our Ilant Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Ilant Health
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Ilant Health?
See current pricing and start your free consultation.